Access cutting-edge celiac disease treatment through this clinical trial at a research site in Miami Lakes. Study-provided care at no cost to qualified participants.
Access celiac disease specialists in Miami Lakes at no cost
This study follows strict safety protocols and ethical guidelines
All study-related celiac disease treatment provided free
This is a Phase 2a/b, randomized, double-blind, placebo-controlled, parallel-group, 6-arm study to evaluate the efficacy and safety of amlitelimab in adult participants with non-responsive celiac disease (NRCD) who are on a gluten free diet (GFD) with and without simulated inadvertent gluten exposure (SIGE). The primary purpose of this study is to demonstrate the efficacy of subcutaneous (SC) amlitelimab in male and female participants (aged 18 to 75 years, inclusive) with NRCD. The study will
Sponsor: Sanofi
Check if you qualify for this celiac disease clinical trial in Miami Lakes, FL
If you're searching for celiac disease treatment options in Miami Lakes, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Miami Lakes research site is actively enrolling participants for this clinical trial. You'll receive care from experienced celiac disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.